To gain further insight into these issues, we examined the relationship between peripheral blood SARS-CoV-2 IFN-γ-producing CD4+ and CD8+ T-cell responses targeting the Spike (S) and membrane (M) proteins, plasma levels of biomarkers of clinical severity and mortality COVID-19 ICU patients. This evidence concerns the gene CD8A and COVID-19.